论文部分内容阅读
据Pediatrics(1995,96:18)载D’Angio等美国研究人员称,看来极早产儿一般能与足月婴儿一样,对按出生后正常时序年龄所给予的常规接种作出应答。 在他们的研究中,16名估计在孕龄<29周出生,出生体重<1000g,可作评定的婴儿按下列程序进行了接种:第一个剂量是白喉、破伤风类毒素、百日咳菌(全细胞)混合制剂(DTP),低聚糖结合b型流感嗜血杆菌(HbOC)和增效灭活、可注射的脊髓灰质炎疫苗(eIPV);年龄在6周至3个月之间。第二个剂量是DTP和HbOC疫苗和eIPV或口服脊髓灰质炎疫苗;年龄在3至5个月之间。第三个剂
According to Pediatrics (1995, 96:18), American researchers including D’Angio said that it appears that very preterm infants generally respond to routine vaccination given at the normal timing of birth, just like full-term infants. In their study, 16 of the infants estimated to be born at <29 weeks gestational age with a birth weight of <1000 g were eligible for vaccination as follows: The first dose was diphtheria, tetanus toxoid, pertussis (DTP), oligosaccharides combined with Haemophilus influenzae type b (HbOC) and synergistic inactivated, injectable polio vaccine (eIPV); between 6 and 3 months of age. The second dose is DTP and HbOC vaccine and eIPV or oral polio vaccine; between 3 and 5 months old. The third dose